Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Kinro Ito"'
Autor:
Kinro Ito, Hideo Tanaka, Takuo Ito, Li-Gen Liu, Taiichi Kyo, Tanvira Afroze Sultana, Akiro Kimura
Publikováno v:
Acta Haematologica. 113:113-123
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an interferon (IFN)-induced molecule with apoptotic activity. We examined gene mutations in the death domains of TRAIL receptor 1 (TRAIL-R1) and TRAIL receptor 2 (TRAIL-R2), and in th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1198049957172cc1fe24378ee256a938
https://doi.org/10.1159/000083449
https://doi.org/10.1159/000083449
Autor:
Takuo Ito, Kimio Tanaka, Taiichi Kyo, Hideo Tanaka, Kinro Ito, Nobuo Oguma, Hiroo Dohy, Akiro Kimura
Publikováno v:
Cancer Genetics and Cytogenetics. 153:133-143
To investigate the relationship of chromosomal aberrations at blastic crisis (BC) in chronic myelogenous leukemia (CML), with previous therapies and with atomic bomb (AB) exposure, we studied 114 CML patients who developed BC, including 23 AB survivo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5dce33914d0f1c087db156433ae010bc
https://doi.org/10.1016/j.cancergencyto.2004.01.019
https://doi.org/10.1016/j.cancergencyto.2004.01.019
Autor:
Hideo Tanaka, Fumio Imanaka, Kinro Ito, Tanvira Afroze Sultana, Taiichi Kyo, Yasukazu Ohmoto, Akiro Kimura, Takuo Ito
Publikováno v:
European Journal of Haematology. 73:191-205
In order to investigate the mechanism of interferon-alpha (IFNalpha) action in the treatment of chronic myelogenous leukemia (CML), we examined surface expressions of both type I interferon receptor 1 (IFNAR1) and 2 (IFNAR2) subunits on CD34-positive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8f8f79e90d8e30cedbd0bb54ea57e80b
https://doi.org/10.1111/j.1600-0609.2004.00275.x
https://doi.org/10.1111/j.1600-0609.2004.00275.x
Autor:
Kinro, Ito, Hideo, Tanaka, Takuo, Ito, Tanvira A, Sultana, Taiichi, Kyo, Fumio, Imanaka, Yasukazu, Ohmoto, Akiro, Kimura
Publikováno v:
European journal of haematology. 73(3)
In order to investigate the mechanism of interferon-alpha (IFNalpha) action in the treatment of chronic myelogenous leukemia (CML), we examined surface expressions of both type I interferon receptor 1 (IFNAR1) and 2 (IFNAR2) subunits on CD34-positive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::037b688ea77669a6920cc29061a77285
https://pubmed.ncbi.nlm.nih.gov/15287917
https://pubmed.ncbi.nlm.nih.gov/15287917
Autor:
Li-Gen, Liu, Hideo, Tanaka, Kinro, Ito, Takuo, Ito, Tanvira A, Sultana, Taiichi, Kyo, Akiro, Kimura
Publikováno v:
Acta haematologica. 113(2)
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an interferon (IFN)-induced molecule with apoptotic activity. We examined gene mutations in the death domains of TRAIL receptor 1 (TRAIL-R1) and TRAIL receptor 2 (TRAIL-R2), and in th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::66b4a716aefada00f8cc2cd9ba862642
https://pubmed.ncbi.nlm.nih.gov/15802890
https://pubmed.ncbi.nlm.nih.gov/15802890
Publikováno v:
American journal of hematology. 74(4)
We describe a patient with chronic myelogenous leukemia (CML), in whom the DNA breakpoint in the BCR-ABL fusion gene was determined to result in a rare e13a3 (b2a3) transcript. The breakpoint in BCR was intron 13, which was 30 bp downstream from exon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7a8942c3450a3812fba6219097d6dae
https://pubmed.ncbi.nlm.nih.gov/14635208
https://pubmed.ncbi.nlm.nih.gov/14635208
Autor:
Tanvira Afroze, Sultana, Hironori, Harada, Kinro, Ito, Hideo, Tanaka, Taiichi, Kyo, Akiro, Kimura
Publikováno v:
British journal of haematology. 121(1)
CD34++ cells from 45 patients with myelodysplastic syndrome (MDS) and MDS-acute myeloid leukaemia (MDS-AML) were observed by flow cytometry for the expression of granulocyte colony-stimulating factor receptor (G-CSFR). Ten patients had a significantl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a4ddc53c62528d02592c8a73ba946f90
https://pubmed.ncbi.nlm.nih.gov/12670333
https://pubmed.ncbi.nlm.nih.gov/12670333
Autor:
Hideo Tanaka, Taiichi Kyo, Akiro Kimura, Takuo Ito, Nanao Kamada, Hiroo Dohy, Kimio Tanaka, Kinro Ito
Publikováno v:
British Journal of Haematology. 126:752-753
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::82cc83ab51b81701fb254e6aef118ea8
https://doi.org/10.1111/j.1365-2141.2004.05119.x
https://doi.org/10.1111/j.1365-2141.2004.05119.x
Publikováno v:
American Journal of Hematology; Dec2003, Vol. 74 Issue 4, p268-272, 5p